University of Alabama Utilizes Mawi’s iSWAB-Protein for…
READ MORE
The iSWAB™-Microbiome (iSWAB™-MB) is a non-toxic, stabilizing sample device designed to maintain the status quo of samples at the time of collection, providing a representative snapshot of the microbial community that remains unchanged from the point of collection to processing. Client Testimonial “We use iSWAB-Microbiome…
READ MORE
Got DNA? Simplifying the First Step in Genomic Testing
Today, collecting DNA seems pretty standard, but not everyone can produce and adequate amount of saliva and bacteria can contaminate the sample causing issues to arise downstream. Why did Mawi DNA Technologies create the iSWAB? To improve and simplify biological sample collection and allow for…
READ MORE
Candida Data Using iSWAB In Response to New Infectious Diseases
A deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The iSWAB-Microbiome-EL has been proven to safely collect and transport samples suspected of containing the infection and has…
READ MORE
Top Reasons to Ditch Your Current VTM. Upgrade your Viral Transport Media
Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior option: 1. FDA Approved* 2. Skip the RNA extraction step in PCR workflow 3. Inactivates viruses and other…
READ MOREInnovate Further with High Quality DNA Samples
iSWAB™-DNA Quick Facts Gentle lytic buffer Non-Toxic and alcohol-free device High recovery of high molecular weight gDNA Insignificant quantities of bacterial DNA contamination Compatible with microarrays and Next Generation Sequencing Stable at room temperature for ~3 years The Mawi team is here to contribute to your team’s…
READ MOREWe Were Featured on NBC News!
https://youtu.be/wWzE63JOhSY We are proud to announce that our President and CTO, Dr. Bassam El-Fahmawi, PhD. was interviewed by NBC News Bay Area reporter Bigad Shaban regarding our iSWAB sample collection tube innovation. The primary purpose of the interview was to discuss its impact on corona…
READ MOREDrive-Thru Coronavirus Testing in Pandemics is Counter-Intuitive. Here’s why.
When dealing with rapidly emerging pandemics such as COVID-19, it is vital for infected individuals to be identified and quarantined as quickly as possible. In an effort to do this, drive-thru testing sites are being introduced nationwide to limit patients interactions with others. While the…
READ MOREMan’s DNA Replaced By His Donors After Transplant
A recent New York Times article reported that Chris Long (a bone marrow transplant recipient) learned that "Swabs of his lips and cheeks contained his DNA — but also that of his donor." This is the exact reason that Mawi DNA Technologies has always chosen…
READ MORESpit DNA Collection Limitations Magnifies Genomics Research Diversity Issue
We have been advocating that the diversity in genomics research is an issue since Mawi DNA’s inception in 2014. Interestingly, in late 2018 and now 2019 several publications came out to describe this issue in greater details. Unfortunately, such gap of genetic data hinders progress…
READ MORETGFBI p.H626R Mutation: Late-Onset Lattice Corneal Dystrophy in Canadian Family
Article Abstract Within the over 70 reported transforming growth factor-beta–induced (TGFBI) corneal dystrophy mutations,1more than 40 are associated with lattice corneal dystrophy (LCD), subtypes I, III, IIIA, and IIIB according to the Human Gene Mutation Database (QIAGEN, Hilden, Germany). This is a follow-up investigation to…
READ MORE
